Masimo Corporation (MASI) News
Filter MASI News Items
MASI News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
MASI News Highlights
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
Latest MASI News From Around the Web
Below are the latest news stories about MASIMO CORP that investors may wish to consider to help them evaluate MASI as an investment opportunity.
Masimo to Present in the 43rd Annual J.P. Morgan Healthcare ConferenceIRVINE, Calif., January 08, 2025--Masimo (NASDAQ: MASI) today announced that its management will participate in the 43rd Annual J.P. Morgan Healthcare Conference on Thursday, January 16, 2025 at 10:30 a.m. Pacific time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com. A replay of the webcast will be available following the live presentation. |
The Zacks Analyst Blog Highlights Veracyte, Omnicell, Masimo and Abbott LaboratoriesVeracyte, Omnicell, Masimo and Abbott Laboratories are included in this Analyst Blog. |
4 Healthcare Technology Innovators to Invest in Before the New YearHere, we have presented four healthcare technology stocks for stable portfolio gains in 2025: VCYT, OMCL, MASI and ABT. |
Those who invested in Masimo (NASDAQ:MASI) a year ago are up 50%These days it's easy to simply buy an index fund, and your returns should (roughly) match the market. But you can... |
3 Medical Instruments Industry Stocks to Buy on the GenAI WaveMASI, PEN and VCYT from the Zacks Medical Instruments industry are worth buying based on genAI adoption, strategic developments and strong fundamentals. Yet, geopolitical complications and wage and supply issues mar their prospects. |
Masimo lays off 75 employees in CaliforniaUnder new leadership, the patient monitoring company is allocating resources to fewer projects as it focuses on market opportunities that address unmet needs, a spokesperson said. |
Why Is Steris (STE) Up 0.9% Since Last Earnings Report?Steris (STE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. |
NARI Stock Likely to Gain Following Reimbursement Approval in JapanInari Medical announces reimbursement approval for ClotTriever Thrombectomy System in Japan and a new distribution partnership with Medikit. |
The Zacks Analyst Blog Highlights MACOM Technology Solutions, Masimo, Leonardo DRS, Ingredion and CarpenterMACOM Technology Solutions, Masimo, Leonardo DRS, Ingredion and Carpenter are included in this Analyst Blog. |
Buy 5 Mid-Cap Stocks Poised to Turn Into Large Caps in 2025These mid-cap stocks have the potential to become large-caps in 2025. These are: MTSI, MASI, DRS, CRS, INGR. |